Yunmei (May) Song is a doctor in pharmaceutics and has wide experience in research and development of drug delivery systems. Her specialist interests include the application and development of innovative technologies and novel dosage forms of drugs and in vitro/in vivo performance evaluation of the preparations. May has undertaken and completed a number of projects, including drug controlled release systems, novel taste masking technologies for oral drugs, oral drug delivery systems giving high bioavailability and improved drug stability. May also has assisted three professors in supervising postgraduates and Ph.D candidates. At UniSA, May is involved with many projects undertaken in the Centre for Pharmaceutical Innovation and... Read more
About me
Yunmei (May) Song is a doctor in pharmaceutics and has wide experience in research and development of drug delivery systems. Her specialist interests include the application and development of innovative technologies and novel dosage forms of drugs and in vitro/in vivo performance evaluation of the preparations. May has undertaken and completed a number of projects, including drug controlled release systems, novel taste masking technologies for oral drugs, oral drug delivery systems giving high bioavailability and improved drug stability. May also has assisted three professors in supervising postgraduates and Ph.D candidates. At UniSA, May is involved with many projects undertaken in the Centre for Pharmaceutical Innovation and Development, where state-of-the-art pilot scale pharmaceutical manufacturing facilities have been established with the assistance of the SA Government. She provides consultant advice to industry undertakes research and development projects and supervises both undergraduate and postgraduate students. Any students considering Honours, Masters or PhD projects are encouraged to visit and discuss options. Besides, May has rich experience in managing a pharmaceutics laboratory. Her laboratory management work covers participation in purchase of instruments and equipment, preliminary layout design of a labortary, support and coordination of public utilities, involvement in installation, commissioning and accpetance inspection of instruments and equipment, construction of a laboratory management system, training and assesment of users and laboratory personnel, use management, maintenance, troubleshooting and repair of instruments and equipment, and external services and exchange.
Research
Excludes commercial-in-confidence projects.
A controlled release peroxide oxygen injection, Quantec, 12/09/2016 - 31/12/2016
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2018 |
Open access
3
|
2018 |
Open access
|
Year | Output |
---|---|
2023 |
|
2023 |
Open access
|
2023 |
Open access
|
2023 |
Open access
|
2023 |
|
2022 |
|
2022 |
Open access
4
4
4
|
2022 |
1
1
4
|
2022 |
5
5
7
|
2022 |
1
1
5
|
2022 |
Open access
1
1
1
|
2022 |
Open access
4
2
|
2022 |
Open access
2
2
3
|
2022 |
Open access
1
1
1
|
2021 |
Open access
8
5
3
|
2021 |
Open access
13
12
2
|
2021 |
Open access
10
7
1
|
2021 |
Open access
1
1
|
2021 |
Open access
9
9
|
2021 |
Open access
7
6
|
2021 |
Open access
4
4
|
2021 |
Open access
11
10
1
|
2021 |
Open access
5
5
3
|
2021 |
10
9
1
|
2021 |
76
68
|
2020 |
Open access
8
7
|
2020 |
Open access
30
27
2
|
2020 |
Open access
6
5
1
|
2020 |
Open access
15
12
99
|
2020 |
Open access
1
1
|
2020 |
Open access
11
11
4
|
2020 |
Open access
1
1
|
2019 |
Open access
13
11
2
|
2019 |
Open access
9
9
1
|
2019 |
Open access
35
27
|
2019 |
Open access
30
26
|
2019 |
Open access
17
16
1
|
2019 |
Open access
15
15
3
|
2018 |
Open access
8
8
5
|
2018 |
30
25
|
2018 |
3
4
1
|
2018 |
Open access
3
6
1
|
2018 |
13
11
|
2018 |
28
23
81
|
2018 |
Open access
2
4
5
|
2018 |
Open access
14
12
1
|
2018 |
Open access
10
9
|
2017 |
2
2
|
2017 |
Open access
10
13
|
2017 |
Open access
1
1
1
|
2017 |
Open access
11
10
|
2017 |
Open access
6
7
1
|
2017 |
Open access
105
96
|
2017 |
Open access
8
8
|
2017 |
Open access
18
20
7
|
2017 |
Open access
15
15
|
2017 |
Open access
14
13
|
2016 |
Open access
26
25
|
2016 |
Open access
7
6
1
|
2016 |
59
55
1
|
2015 |
1
1
1
|
2015 |
Open access
36
32
|
2015 |
Open access
14
14
|
2015 |
Open access
6
6
|
2015 |
Open access
19
19
|
2011 |
Open access
38
36
|
2011 |
11
9
|
2011 |
Open access
55
48
|
2010 |
6
5
|
2010 |
82
62
|
2010 |
Open access
48
17
|
2009 |
97
87
|
2008 |
19
19
|
2008 |
43
33
|
Research
External engagement & recognition
Organisation | Country |
---|---|
Advanced Veterinary Therapeutics | AUSTRALIA |
Chalmers University of Technology | SWEDEN |
China Pharmaceutical University | CHINA |
Chuulangun Aboriginal Corporation | AUSTRALIA |
Daping Hospital | CHINA |
Deakin University | AUSTRALIA |
Dermatology for Animals | AUSTRALIA |
Flinders Medical Centre | AUSTRALIA |
Flinders University | AUSTRALIA |
Fudan University | CHINA |
Kansas State University | UNITED STATES |
Luoda Pharma Pty Ltd | AUSTRALIA |
Monash University | AUSTRALIA |
Neoculi Pty. Ltd. | AUSTRALIA |
Peking University | CHINA |
Queen Elizabeth Hospital | AUSTRALIA |
Rush University | UNITED STATES |
SA Health | AUSTRALIA |
Shandong Provincial Qianfoshan Hospital | CHINA |
Shandong University | CHINA |
SunPork Group | AUSTRALIA |
University of Adelaide | AUSTRALIA |
University of Bristol | UNITED KINGDOM |
University of California | UNITED STATES |
University of Canberra | AUSTRALIA |
University of Kansas | UNITED STATES |
University of Otago | NEW ZEALAND |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Western Australia | AUSTRALIA |
Vaxine Pty Ltd | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
MemberAustralasian Pharmaceutical Science Association (APSA) |
2018 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
3D Printed Biodegradable Films for Targeted Chemotherapy in Liver Cancer | Current |
Development of 3D printed patient-centric cannabidiol and estrogen films: a move towards personalised medicine | Current |
Development of a novel controlled release anticancer drugs delivery system using 3D printing | Current |
Development of novel delivery system for immune checkpoint inhibitors using 3D printed microneedle patches for melanoma | Current |
Novel antimicrobials delivery systems for multi drug resistant infections | Current |
Re-positioning of existing drugs as antimicrobial agents for resistant infections. | Current |
Development of drug-eluting stents for the localised delivery of 5-fluorouracil targeted towards the treatment of gastrointestinal cancers | Completed |
Development of drug-eluting stents using dip-coating and 3D printing techniques for the localised treatment of oesophageal cancer | Completed |
Development of monocyte targeted delivery system for doxorubicin using modified inulin particles | Completed |
Development of novel micro-reservoir based buccal mucosal drug delivery systems | Completed |
Evaluation of the role of pH in wound healing and development of buffered preparations to promote regeneration | Completed |
Intracellular and localized drug delivery using inulin | Completed |
Novel functionalized mesoporous silica nanoparticles as targeted delivery systems to estrogen receptor-overexpressing breast cancer | Completed |
Three-dimensional printing of biodegradable polymeric scaffold for cancer therapy | Completed |